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Abstract
Objectives To investigate the diagnostic accuracy of CT
coronary angiography (CTCA) in women at low to interme-
diate pre-test probability of coronary artery disease (CAD)
compared with men.
Methods In this retrospective study we included symptom-
atic patients with low to intermediate risk who underwent
both invasive coronary angiography and CTCA. Exclusion
criteria were previous revascularisation or myocardial in-
farction. The pre-test probability of CAD was estimated
using the Duke risk score. Thresholds of less than 30 %
and 30–90 % were used for determining low and interme-
diate risk, respectively. The diagnostic accuracy of CTCA in
detecting obstructive CAD (≥50 % lumen diameter narrow-
ing) was calculated on patient level. P<0.05 was considered
significant.
Results A total of 570 patients (46 % women [262/570])
were included and stratified as low (women 73 % [80/109])
and intermediate risk (women 39 % [182/461]). Sensitivity,
specificity, PPV and NPV were not significantly different in
and between women and men at low and intermediate risk.
For women vs. men at low risk they were 97 % vs. 100 %,
79 % vs. 90 %, 80 % vs. 80 % and 97 % vs. 100 %,
respectively. For intermediate risk they were 99 % vs.
99 %, 72 % vs. 83 %, 88 % vs. 93 % and 98 % vs. 99 %,
respectively.
Conclusion CTCA has similar diagnostic accuracy in wom-
en and men at low and intermediate risk.
Key Points
• Coronary artery disease (CAD) is increasingly investigat-
ed by computed tomography angiography (CTCA).
• CAD detection or exclusion by CTCA is not different
between sexes.
• CTCA diagnostic accuracy was similar between low and
intermediate risk sex-specific-groups.
• CTCA rarely misses obstructive CAD in low–intermediate
risk women and men.
• CAD yield by invasive coronary angiography after positive
CTCA is similar between sex-risk-specific groups.
Keywords Diagnostic accuracy .CTcoronary angiography .
Multidetector computed tomography . Coronary artery
disease . Duke pre-test probability . Sex, women and men
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Introduction
Cardiovascular disease is the leading cause of death in the
western world [1]. For several years awareness has been
growing that cardiovascular disease is also the primary
cause of death in women not only in the western world but
also in economic developing countries [2]. Part of this high
mortality is related to under-recognition, underdiagnosis and
undertreatment of coronary artery disease (CAD) in women
[3–7].
The interpretation of chest pain in women caused by
CAD is often difficult because of the “less typical” symp-
toms in women compared with the classical “typical” symp-
toms in men [3, 4, 8]. This may cause a delay or lead to
incorrect diagnosis [3, 4]. Additionally first-line non-inva-
sive diagnostic tests such as exercise electrocardiography
and single photon emission computed tomography (SPECT)
imaging in women are less sensitive and specific [5, 6].
Paradoxically, because of the diagnostic uncertainty there
appears to be an overuse of invasive coronary angiography
(ICA) in women, with a rather low diagnostic yield of
obstructive CAD [9, 10]. This prompted a “red alert call”
for the promotion of advanced non-invasive imaging tech-
niques in women including CT coronary angiography
(CTCA) [11]. CTCA has evolved as a reliable gatekeeper
of ICA because negative CT findings virtually rule out the
presence of obstructive CAD [12–14]. Whether this also
applies to women remains unresolved because women have
been under-represented in studies assessing the diagnostic
accuracy of CTCA [12–17]. The pre-test probability (PTP)
of obstructive CAD plays a significant role in the assess-
ment of the clinical utility of CTCA. This PTP of obstruc-
tive CAD can be derived from reported clinical prediction
rules [18] and may influence the post-CTCA probability of
obstructive CAD and thus the need for further testing and
management.
The purpose of our study was to assess the diagnostic
accuracy and clinical utility of CTCA to detect or exclude
obstructive CAD in women with low to intermediate PTP of
obstructive CAD in comparison to men.
Methods and materials
Study population
Patients referred by their treating physician for ICA between
July 2004 and June 2009 on the basis of chest pain
presentation (typical, atypical and non-anginal complaints)
with or without outcome of stress testing were invited to
undergo CTCAwithin 2 weeks of ICA. The CTCA outcome
did not affect referral to ICA. We excluded patients with
known iodine allergy, impaired renal function and patients
with previous revascularisation. A total of 907 patients gave
consent for CT accuracy studies and were entered in our
single-centre registry. Out of these 907 patients we excluded
patients with previous myocardial infarct (n054) as well as
patients with a high PTP (>90 %) of having obstructive
CAD (n0283). The final study sample comprised a total
of 570 symptomatic patients. The study was approved by
the institutional review board of our medical hospital.
Computed tomography imaging protocol and image
reconstruction
Patients underwent single-source CT (Somatom Sensation,
Siemens Healthcare, Forchheim, Germany) between 2004
and 2006 and subsequently underwent dual-source CT
(Somatom Definition, Siemens Healthcare). The imaging
settings are described in Table 1. Heart-rate-lowering med-
ication (Metoprolol, Seloken, Astra Zeneca, Zoetermeer,
Netherlands) was administered when the heart rate was
above 65 beats per minute before the single-source CT in
the absence of contraindications to achieve better quality
images. To achieve better visualisation of the small coronary
arteries the vasodilating agent Nitrolingual (Nitroglycerin
Pumpspray, G.Pohl-boskamp, Itohenlockstedt, Germany)
was administered before imaging in the absence of
contraindications.
All patients initially underwent unenhanced CT to calcu-
late the calcium score using the Agatston method [19].
Subsequently a bolus tracking technique was used to syn-
chronise the start of image acquisition with the arrival of the
iodinated contrast agent [Iomeprol, iomeron (400 milligram
iodine per millilitre), Bracco, Milan, Italy; Ultravist, iopro-
mide (370 milligram iodine per millilitre), Schering Berlin,
Germany] in the coronary arteries followed by a saline chaser.
Between 2004 and 2006 a full-dose ECG-synchronised
spiral imaging technique was used. After the introduction of
ECG-triggered tube current modulation, the spiral imaging
technique with ECG pulsing was used in the subsequent
years to reduce the effective radiation dose. Data sets were
reconstructed retrospectively according to the heart rate to
obtain motion-free images. For heart rates of at least 80
beats per minute the data sets were reconstructed in 31–
47 % of the R–R interval (systolic phases). For heart rates of
no greater than 65 beats per minute this value was 60–76 %
of the R–R interval (diastolic phases). For heart rates be-
tween 66 and 79 beats per minute reconstructions were
needed in both systolic and diastolic phases, 30–77 % of
the R–R interval. Images were analysed using medium-to-
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smooth convolution kernels for non-calcified lesions and
sharp convolution kernels for calcified lesions.
Computed tomography image evaluation
All data sets were transferred for analyses to an offline
proprietary workstation (Leonardo, Siemens, Erlangen, Ger-
many); the total calcium score was calculated using dedi-
cated proprietary software (CaScoring). Two experienced
observers with more than 2 years of experience in cardiac
CT, blinded to the ICA results, independently evaluated all
CTCAs for the presence of CAD, using axial source images,
multiplanar, curved reformatted reconstructions, and thin-
slab maximum intensity projections using “Circulation”
software on the proprietary workstation. Interobserver dis-
agreements were resolved by a joint consensus reading.
The modified 17-segment American Heart Association
model was used to classify each segment [20]. Each seg-
ment was visually scored as obstructive in the presence of at
least 50 % lumen diameter narrowing and non-obstructive
when the lumen diameter narrowing was less than 50 % in
comparison with the proximal and distal lumen. All anatom-
ically available coronary segments with a diameter of at
least 1.5 mm, irrespective of image quality or calcification,
were included and scored with the intention to diagnose.
Un-evaluable segments of poor quality due to calcification,
stack, motion artefacts, or low contrast enhancement were
scored as obstructive. Coronary segments distal to a total
occlusion could not be optimally visualised by ICA and thus
were excluded from the analyses. The image quality was
scored on a segment level as diagnostic and non-diagnostic.
The average of this score per patient was compared between
women and men.
Invasive coronary angiogram image evaluation
One experienced cardiologist, blinded to the CT results,
visually assessed each coronary segment (American Heart
Association model) for the presence of luminal narrowing in
two orthogonal planes. Stenoses scored as having more than
20 % narrowing on visual assessment were quantified using
the validated quantitative coronary angiography (QCA) al-
gorithm (CAASII [Cardiovascular Angiography Analysis
System II]; Pie Medical Imaging Maastricht, the Nether-
lands). The segments were considered obstructive when
the quantified lumen diameter narrowing in one of the two
planes was at least 50 %. Obstructive lesions on a segment
level were used to determine obstructive CAD on a patient
level as having one or more obstructive stenoses (≥50 %
lumen diameter stenosis) irrespective of the segment in
which they were located.
PTP of obstructive CAD
We used the Duke risk score [18] to estimate the PTP of
obstructive CAD due to the presence of multiple risk factors
such as age, gender, symptoms, history of myocardial in-
farction, ECG, smoking, hypercholesterolaemia and diabe-
tes mellitus. We used less than 30 %, 30–90 %, and greater
than 90 % as thresholds for the low, intermediate and high
risk group, respectively. As patients with a high risk are
directly referred for ICAwe did not include these patients in
our analyses [21, 22].
The observed PTP of obstructive CAD is the prevalence
of obstructive CAD defined as having at least one lesion
with at least 50 % lumen diameter stenosis per patient
detected by ICA.
Statistical analyses
The statistical analysis was performed using a dedicated
statistical software program (SPSS, version 16.0, IMB, Chi-
cago, IL, USA). Categorical variables were expressed as
percentages and continuous variables were expressed as
means ± standard deviation. Continuous variables with a
Table 1 Imaging protocol
SSCTb DSCTc
β-blockera Yes No
Nitroglycerina No Yes
X-ray tube 1 2
Collimation 32×0.6 (Z-FFS) 32×0.6 (Z-FFS)
Gantry rotation time (ms) 330 330
Temporal resolution (ms) 165 83
Spatial resolution (mm) 0.4×0.4×0.4 0.4×0.4×0.4
Pitch 0.2 0.2–0.53
Rotation time (ms) 330 330
Unenhanced imaging
Tube voltage (kV) 120 120
Tube current 200–150 effective
mAs
75 mAs/rotation
ECG-triggered tube current
modulation
Yes Yes
Contrast-enhanced imaging
Tube voltage (kV) 120 120
Tube current 850–960
effective mAs
320–412 mAs/
rotation
ECG-triggered tube current
modulation
No Yes
SSCT single-source CT, DSCT dual-source CT, Z-FFS Z-flying focal
spot, ECG electrocardiogram, mAs/rotation total mA × rotation time
a Administration before imaging when no contraindication was present
b Somatom Sensation, Siemens Healthcare, Forchheim, Germany
c Somatom Definition, Siemens Healthcare, Forchheim, Germany
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skewed distribution were expressed as median with inter-
quartile range.
The estimated PTP was compared in women, men and in
the different risk groups with the observed PTP (observed
prevalence) using the paired t test.
The patients’ characteristics were compared between
women and men and between different risk groups using
the independent t test; otherwise the Mann-Whitney U test
was used (skewed distribution of continuous data). The
interobserver variability was tested between the two CT
readers on segment and patient level using the κ statistic.
The CTCA results were compared with the reference stan-
dard ICA on a patient level to calculate the sensitivity (SN),
specificity (SP), positive predictive value (PPV) and negative
predictive value (NPV) [23]. The Wilson score [24] was used
to calculate the confidence intervals for small groups. The
diagnostic accuracy and utility were compared across the
different risk groups, between women and men using the
chi-squared test or the Fisher’s exact test in the presence of
less than five observations in a cell of the 2×2 table. A P value
of less than 0.05 was considered statistically significant.
The receiver-operating characteristic (ROC) curve was
used for visual analyses of the trade-offs between the sensi-
tivity and the specificity of CTCA. The area under the ROC
curve (AUC) was calculated to account for the influence of
referral bias and prevalence of disease on the diagnostic
accuracy of CTCA in our population [25, 26].
The clinical utility of CTCAwas a measure of diagnostic
certainty or remaining uncertainty of absence or presence of
CAD that is derived from the post-test probability of CAD.
In case of diagnostic certainty no further testing is required,
whereas remaining uncertainty requires further diagnostic
testing. It was assumed that a post-test probability of ob-
structive CAD of less than 5% indicated high certainty with
no further requirement for diagnostic testing; probabilities
between 5 and 90 % represented uncertainty and indicated a
requirement for further diagnostic testing; and probabilities
of greater than 90 % indicated high certainty with direct
referral to ICA, as proposed by previous studies [27].
This study was performed according to the criteria set forth
in the Standard for Reporting of Diagnostic Accuracy Initiative
[28].
Results
In total, 570 patients at low to intermediate risk were in-
cluded of which 46 % were women (n0262). The patients’
characteristics are provided according to sex and risk group
in Table 2. Women overall had a significantly higher heart
rate (HR) than men (P00.03). The HR was similar in the
different risk groups (Table 2). The prevalence of CAD (at
least one obstructive lesion) in women was 61 % and in men
this was 64 % (P00.42). The PTP of obstructive CAD
determined by the Duke risk score (estimated PTP) was
significantly lower than the observed prevalence of obstruc-
tive CAD determined by ICA in women in the overall group
(45 % vs. 61 %, P<0.01) as well as in the low (17 % vs.
48 %, P<0.01) and intermediate risk groups (60 % vs. 66 %,
P00.02) separately. In men there was no difference between
the estimated PTP and observed prevalence (overall 65 %
vs. 64 %, P00.56; low 21 % vs. 28 %, P00.43; intermediate
risk group (70 % vs. 68 %, P00.38).
In this population the prevalence of obstructive CAD and
extent of CAD in terms of multi-vessel disease and calcium
score were similar between women and men (Table 2).
The interobserver variability for detection of obstructive
stenosis showed a good agreement on segment (κ00.94 [95%
CI 0.93–0.95]) and patient levels (κ00.91 [95 % CI 0.87–
0.95]). The diagnostic image quality was not significantly
different between women and men (0.96 vs. 0.97, P00.06).
Diagnostic accuracy of CTCA
The patient-based diagnostic accuracy of CTCA for detecting
or ruling out obstructive CAD according to ICA revealed an
AUC of 0.895 (95 % CI: 0.862 - 0.928) which was similar
between women and men (0.867 [95 % CI: 0.815 - 0.920] vs.
0.921 [95 % CI: 0.880 - 0.961], P00.06), with similar sensi-
tivity and specificity for women and men when grouped in the
low and intermediate risk groups and across the low and
intermediate risk groups in both women and men (Table 3).
Because different CT systems were used over the years we
also assessed the diagnostic performance for detecting CAD
between these two machines. No significant differences were
found between the single-source and dual-source CT systems
for sensitivity (99 % vs. 99 %, P00.93), specificity (84 % vs.
75 %, P00.10), positive predictive value (85 % vs. 91 %, P0
0.06) and negative predictive value (99 % vs. 97 %, P00.39).
Clinical utility of CTCA
Certainty defined as probabilities for obstructive CAD of no
greater than 5 % after negative CTCA was achieved in both
women (NPV 97 % and 98 % for low and intermediate risk,
respectively) and men (NPV 100 % and 99 % for low and
intermediate risk, respectively) at low to intermediate risk. No
certainty of obstructive CAD after positive CTCA could be
achieved (probability <90%) in women at low (PPV 80%) and
intermediate risk (PPV 88 %), and men at low risk (PPV 80 %)
(Table 3).
Yield of obstructive CAD by ICA after CTCA
A negative CTCAwould prevent 31% (174/570) of the low to
intermediate risk patients proceeding to ICA (30 % (79/262)
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women; 31 % (95/308) men, P00.86; Fig. 1). This prevention
of ICAwould be more pronounced in patients at low risk (low
49 % (53/109) vs. intermediate 26 % (121/461), P<0.001)
compared to patients at intermediate risk. Obstructive CAD
would be missed in less than 1 % after a negative CTCAwith
no significant differences between women and men (1 % (2/
262) women vs. 0 % (1/308) men, P00.48), or between the
low and intermediate risk groups (1 % (1/109) low vs. 0 % (2/
461) intermediate risk group, P00.52). A positive CTCA
would result in 89 % (353/396) yield of obstructive CAD by
ICAwith no significant differences between women and men
(86 % (157/183) women vs. 92 % (196/213) men, P00.0502)
or between the low and intermediate risk groups (80% (45/56)
low vs. 91 % (308/340) intermediate risk group, P00.06).
Discussion
In our clinical evaluation of CTCA in low to intermediate
risk women and men with suspected CAD who were
Table 2 Patients’ characteristics
All Low Intermediate
Women Men Women Men Women Men
Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD]
Number patients 262 308 80 29 182 279
Age (years) 62* [10.96] 55* [9.52] 54* [8.58] 40* [8.15] 66* [9.57] 57* [8.18]
Chest pain complaintsa
Typical 30 %* (78) [0.46] 20 %* (63) [0.40] 1 %* (1) [0.11] 0 %* (0) [0.00] 42 %* (77) [0.50] 23 %* (63) [0.42]
Atypical 38 %* (100) [0.49] 50 %* (155) [0.50] 49 %* (39) [0.50] 41 %* (12) [0.50] 34 %* (61) [0.47] 51 %* (143) [0.50]
Non-anginal 32 % (84) [0.47] 29 % (90) [0.46] 50 % (40) [0.50] 59 % (17) [0.50] 24 % (44) [0.43] 26 % (73) [0.44]
Current smoker 23 % (59) [0.42] 28 % (86) [0.45] 14 % (11) [0.34] 10 % (3) [0.31] 26 % (48) [0.44] 29 % (83) [0.46]
Diabetes mellitusb 16 % (43) [0.37] 12 % (36) [0.33] 4 % (3) [0.19] 0 % (0) [0.00] 22 %* (40) [0.42] 13 %* (36) [0.34]
CAD in familyc 55 %* (143) [0.50] 44 %* (137) [0.50] 59 % (47) [0.50] 41 % (12) [0.50] 53 % (96) [0.50] 45 % (125) [0.50]
Hypercholesterolaemiad 56 %* (147) [0.50] 44 %* (135) [0.50] 41 %* (35) [0.50] 10 %* (3) [0.31] 62 %* (112) [0.49] 47 %* (132) [0.50]
Hypertensione 52 %* (138) [0.50] 40 %* (122) [0.49] 48 %* (38) [0.50] 10 %* (3) [0.31] 54 %* (100) [0.50] 42 %* (119) [0.50]
Body mass index
(kg/m2)
27 [4.45] 27 [3.51] 27 [4.62] 26 [2.56] 27 [4.38] 27 [3.59]
Calcium scoref 139* [5–446] 349* [9–401] 20 [0–194] 2 [0–65] 211 [36–613] 155 [14–444]
Prevalence CAD
segments/patientg
9 % [0.11] 10 % [0.12] 7 %* [0.09] 3 %* [0.06] 10 % [0.11] 11 % [0.13]
One vessel disease 35 % (92) [0.48] 32 % (98) [0.47] 33 % (26) [0.47] 21 % (6) [0.41] 36 % (66) [0.48] 33 % (92) [0.47]
Multi-vessel diseaseh 25 % (65) [0.43] 32 % (99) [0.47] 14 % (11) [0.35] 7 % (2) [0.26] 30 % (54) [0.46] 35 % (97) [0.48]
Estimated PTPi 45 %* [0.25] 65 %* [0.21] 17 %* [0.07] 21 %* [0.08] 60 %* [0.18] 70 %* [0.17]
Observed PTPj 61 % (159) [0.49] 64 % (197) [0.48] 48 % (38) [0.50] 28 % (8) [0.45] 66 % (121) [0.47] 68 % (189) [0.47]
HR (beats per minute) 67* [11.94] 65* [12.64] 67 [11.91] 65 [13.78] 67 [11.98] 65 [12.54]
Radiation exposure
(mSv)k
12 [3.78] 12 [4.05] 12 [3.24] 13 [3.56] 12 [3.92] 12 [4.09]
Data in parentheses are number of patients. Data in brackets are the standard deviations and for the calcium score the 25th and 75th percentiles
*Bold values represent significant values (P<0.05) in the comparison between women and men using Student’s t test or Mann–Whitney U test
(italics)
aWe defined typical angina as substernal discomfort that was precipitated by physical exertion or emotion and relieved by rest or nitroglycerin
within 10 min. We classified chest pain with only 1 or 2 of these 3 symptom characteristics as atypical angina pectoris; if none of the characteristics
was present, we classified it as non-anginal chest pain
b Treatment with oral antidiabetic medication or insulin
c Patient had first- or second-degree relatives with premature CAD
d Total cholesterol >180 mg/dl or treatment for hypercholesterolaemia
e Blood pressure >120/90 mmHg or treatment for hypertension
f Agatston score with median and [interquartile range]
g [(Number diseased segments×100%)/(total of number segments)] per patient
h >1 vessel with obstructive CAD detected by ICA
i Estimated pre-test probability of obstructive CAD [18]: low, <30 % (estimated PTP); intermediate, 30–90 % (estimated PTP)
j Prevalence of obstructive CAD on a patient level: observed probability of obstructive CAD determined by ICA
kmSv (millisievert): dose length product×0.017
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referred for ICA but underwent additional CTCA we found
that:
& The Duke risk score underestimated the prevalence of
angiographically obstructive CAD in women, especially
in those at low risk;
& The sensitivity and specificity of CTCA were similar
across low and intermediate risk groups in and between
women and men;
& The clinical utility of a positive CTCA was moderate,
with remaining diagnostic uncertainty in low to interme-
diate risk women and low risk men requiring additional
functional testing;
& The yield of obstructive CAD by ICA was similar in
women and men with low and intermediate risk;
& CTCAwas highly accurate in excluding the presence of
obstructive CAD in women and men at low and inter-
mediate risk.
In our study the overall predicted probability of having
obstructive CAD using the Duke risk score was underesti-
mated in women (45 % vs. 61 %, P<0.01) compared with
the actual presence of CAD assessed by ICA. This finding
probably reflects the difficulties of evaluating women with
symptoms suspected of CAD and has been described in
previous studies [3, 8]. Physicians may misclassify the
Fig. 1 CAD detection by CTCA and its influence on the yield of CAD by ICA
Table 3 Diagnostic accuracy and clinical utility of CTCA between women and men across different risk groups
Risk groups Women Men Women Men P value
(W–M)
n n SN SP PPV NPV SN SP PPV NPV
All TP 157 196 SN 99 [96–100] 99 [97–100] 0.59*
TN 77 94 SP 77 [66–82] 85 [77–90] 0.07
FP 26 17 PPV 86 [80–90] 92 [88–95] 0.047
FN 2 1 NPV 97 [91–99] 99 [94–100] 0.59*
Low TP 37 8 SN 97 [87–100] 100 [68–100] 1.00*
TN 33 19 SP 79 [64–88] 90 [71–97] 0.31*
FP 9 2 PPV 80 [67–89] 80 [49–94] 1.00*
FN 1 0 NPV 97 [85–99] 100 [83–100] 1.00*
Intermediate TP 120 188 SN 99 [95–100] 99 [97–100] 1.00*
TN 44 75 SP 72 [60–82] 83 [74–90] 0.10
FP 17 15 PPV 88 [81–92] 93 [88–96] 0.12
FN 1 1 NP 98 [88–100] 99 [93–100] 1.00*
P value (L–I) 0.42* 0.46 0.23 1.00* 1.00* 0.52* 0.19* 1.00*
The diagnostic accuracy (SN, SP) and clinical utility (PPV, NPV) values are expressed as percentages with [95 % confidence interval]. Estimated
PTP [18] <30 % was defined as low and 30–90 % as belonging to the intermediate risk group. P value L–I (low vs. intermediate risk group) and W–
M (women vs. men) estimated using chi-squared test and (*) Fisher’s exact test
TP true positive, TN true negative, FP false positive, FN false negative, SN sensitivity, SP specificity, PPV positive predictive value, NPV negative
predictive value
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symptoms as non-anginal or atypical angina in women,
which consequently affects the Duke risk score where symp-
tom presentation plays a significant role in the calculation of
the PTP. Underestimation of the Duke risk score may also be
related to the referral bias of our study population, in par-
ticular in women who were referred by their treating physi-
cians for ICA.
It is noteworthy that the diagnostic accuracy of CTCA in
detecting obstructive CAD was similar in women and men
(Table 3; sensitivity 99 % vs. 99 %; specificity 77 % vs. 85 %
for women and men, respectively). Similar findings were
shown by Meijboom et al. in a multicentre study (sensitivity
100 % vs. 99 %; specificity 63 % vs. 66 %) [14] and by
Pundziute et al. in a single-centre study (sensitivity 95 %
vs.100 %; specificity 93 % vs. 89 % for women and men,
respectively) [29]. This is in contrast to the reported technical
limitations and diminished accuracy in women of other non-
invasive ischaemia tests [6, 30] and underscores the gender
neutrality (equality) of the diagnostic accuracy of CTCA.
The clinical utility of CTCA, i.e. reflecting the remaining
diagnostic certainty of the presence or absence of significant
CAD, is an important criterion in the overall clinical assess-
ment of CTCA. The clinical utility is derived from the post-
test probability of CAD and even with the same diagnostic
accuracy of a test (sensitivity/specificity) it is different in
patients with low or intermediate PTP of CAD. We arbi-
trarily assumed that in patients with a post-test probability of
less than 5 % or greater than 90 % sufficient diagnostic
certainty was achieved and no further diagnostic testing was
required. In patients with a post-test probability between
5 % and 90 % diagnostic certainty was not sufficient and
in these patients further diagnostic testing was deemed nec-
essary. In our population we found that the clinical utility of
a positive CTCA was high (>90 %) in men at intermediate
PTP of CAD and further diagnostic testing was not neces-
sary. These patients may then be referred to ICA. The
clinical utility of a positive CTCA was moderate in women
at low to intermediate PTP and in men of low PTP of CAD.
In these patients diagnostic certainty was insufficient and
further diagnostic testing may be needed. Higher certainty
may be then achieved by functional testing for ischaemia
e.g. by SPECT or by stress echocardiography [31, 32].
The clinical utility of a negative CTCA was high in
women and men at low or intermediate PTP of CAD pro-
viding high certainty (<5 %) of absence of obstructive CAD,
and no further testing would be necessary. It has been shown
in numerous studies that the absence of CAD detected by
CTCA is associated with an excellent prognosis [33, 34],
which further lends support that these patients may be safely
discharged. It should be noted that in patients with persistent
chest complaints due to microvascular dysfunction, normal
CT findings with no obstructive epicardial CAD may be
seen [35]. In these patients, who are often women, further
diagnostic testing for ischaemia to detect microvascular
dysfunction will be needed to adjust clinical management
and survival [36].
Recent studies reported that the yield of elective ICA to
demonstrate the presence of obstructive CAD in women and
men is 27–49 % and 47–67 %, respectively, in patients
referred for ICA [9, 10], whereas by performing CTCA
before diagnostic ICA the yield may improve to 86 % for
women and 92 % for men (Fig. 1) and may decrease the
number of unnecessary ICA in women and men by 30 %
and 31 %, respectively, as suggested by our study.
Our study has limitations. Referral bias was present, be-
cause the patients in our population were referred by their
treating physicians to undergo invasive coronary imaging on
the basis of their chest pain presentation with or without
outcome of stress testing. This may explain the relatively high
prevalence of obstructive CAD, in particular in women. To
account for the influence of referral bias on the diagnostic
accuracy [25, 26] of CTCAwe also reported the AUC which
was not different between women and men (0.87 vs. 0.92, P0
0.056). Our study population only consisted of stable patients
and our results may not apply to the wider spectrum of patients
with suspected CAD who did not undergo ICA or who have
unstable symptoms. Of concern was the rather high radiation
exposure of CTCA (12 mSv) due to the use of a retrospective
imaging protocol, which was standard in first-generation CT
[14, 37]. Currently with the newer-generation systems and
optimal imaging protocols much lower levels of radiation
exposure (<3 mSv) can be achieved in patients with low heart
rates (<65 beats per minute) [38].
In conclusion, computed tomography coronary angiogra-
phy has similar diagnostic accuracy in women and men with
low and intermediate risk, and may function as an efficient
gatekeeper for ICA in women as well as in men.
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